nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetirizine—Polyuria—Capecitabine—esophageal cancer	0.00437	0.00443	CcSEcCtD
Cetirizine—Bone disorder—Methotrexate—esophageal cancer	0.00435	0.00442	CcSEcCtD
Cetirizine—Vascular purpura—Capecitabine—esophageal cancer	0.00429	0.00435	CcSEcCtD
Cetirizine—Deafness—Capecitabine—esophageal cancer	0.00429	0.00435	CcSEcCtD
Cetirizine—Herpes simplex—Methotrexate—esophageal cancer	0.00427	0.00433	CcSEcCtD
Cetirizine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00425	0.00431	CcSEcCtD
Cetirizine—Eye pain—Capecitabine—esophageal cancer	0.00425	0.00431	CcSEcCtD
Cetirizine—Libido decreased—Capecitabine—esophageal cancer	0.00414	0.0042	CcSEcCtD
Cetirizine—Hot flush—Capecitabine—esophageal cancer	0.0041	0.00416	CcSEcCtD
Cetirizine—Increased appetite—Capecitabine—esophageal cancer	0.00408	0.00414	CcSEcCtD
Cetirizine—Amnesia—Capecitabine—esophageal cancer	0.00408	0.00414	CcSEcCtD
Cetirizine—Menopausal symptoms—Capecitabine—esophageal cancer	0.00406	0.00413	CcSEcCtD
Cetirizine—Flunarizine—CYP2A6—esophageal cancer	0.00404	0.271	CrCbGaD
Cetirizine—Thirst—Capecitabine—esophageal cancer	0.00403	0.00409	CcSEcCtD
Cetirizine—Dermatitis bullous—Capecitabine—esophageal cancer	0.00401	0.00407	CcSEcCtD
Cetirizine—Purpura—Capecitabine—esophageal cancer	0.00398	0.00404	CcSEcCtD
Cetirizine—Arthritis—Capecitabine—esophageal cancer	0.00395	0.00401	CcSEcCtD
Cetirizine—Vaginal inflammation—Methotrexate—esophageal cancer	0.00393	0.00399	CcSEcCtD
Cetirizine—Cardiac failure—Capecitabine—esophageal cancer	0.00393	0.00399	CcSEcCtD
Cetirizine—Stomatitis—Cisplatin—esophageal cancer	0.00391	0.00397	CcSEcCtD
Cetirizine—Conjunctivitis—Cisplatin—esophageal cancer	0.0039	0.00396	CcSEcCtD
Cetirizine—Melaena—Methotrexate—esophageal cancer	0.00384	0.0039	CcSEcCtD
Cetirizine—Cystitis noninfective—Methotrexate—esophageal cancer	0.00384	0.0039	CcSEcCtD
Cetirizine—Osteoarthritis—Capecitabine—esophageal cancer	0.00384	0.00389	CcSEcCtD
Cetirizine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.0038	0.00386	CcSEcCtD
Cetirizine—Cystitis—Methotrexate—esophageal cancer	0.0038	0.00386	CcSEcCtD
Cetirizine—Migraine—Capecitabine—esophageal cancer	0.00377	0.00383	CcSEcCtD
Cetirizine—Vaginal infection—Methotrexate—esophageal cancer	0.00371	0.00377	CcSEcCtD
Cetirizine—Face oedema—Capecitabine—esophageal cancer	0.0037	0.00376	CcSEcCtD
Cetirizine—Irritability—Capecitabine—esophageal cancer	0.00366	0.00372	CcSEcCtD
Cetirizine—Urinary retention—Capecitabine—esophageal cancer	0.00365	0.0037	CcSEcCtD
Cetirizine—Mood swings—Capecitabine—esophageal cancer	0.00363	0.00369	CcSEcCtD
Cetirizine—Ataxia—Capecitabine—esophageal cancer	0.00361	0.00366	CcSEcCtD
Cetirizine—Dehydration—Capecitabine—esophageal cancer	0.00357	0.00362	CcSEcCtD
Cetirizine—Urine output increased—Methotrexate—esophageal cancer	0.00356	0.00361	CcSEcCtD
Cetirizine—Bladder pain—Methotrexate—esophageal cancer	0.00356	0.00361	CcSEcCtD
Cetirizine—Mouth ulceration—Methotrexate—esophageal cancer	0.00356	0.00361	CcSEcCtD
Cetirizine—Urinary tract disorder—Cisplatin—esophageal cancer	0.00355	0.00361	CcSEcCtD
Cetirizine—Urethral disorder—Cisplatin—esophageal cancer	0.00353	0.00358	CcSEcCtD
Cetirizine—Dry skin—Capecitabine—esophageal cancer	0.00352	0.00357	CcSEcCtD
Cetirizine—Visual impairment—Cisplatin—esophageal cancer	0.00347	0.00352	CcSEcCtD
Cetirizine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00343	0.00348	CcSEcCtD
Cetirizine—Gastritis—Capecitabine—esophageal cancer	0.00339	0.00345	CcSEcCtD
Cetirizine—Muscular weakness—Capecitabine—esophageal cancer	0.00338	0.00343	CcSEcCtD
Cetirizine—Eye disorder—Cisplatin—esophageal cancer	0.00336	0.00341	CcSEcCtD
Cetirizine—Tinnitus—Cisplatin—esophageal cancer	0.00336	0.00341	CcSEcCtD
Cetirizine—Lymphadenopathy—Methotrexate—esophageal cancer	0.00335	0.0034	CcSEcCtD
Cetirizine—Flushing—Cisplatin—esophageal cancer	0.00334	0.00339	CcSEcCtD
Cetirizine—Cardiac disorder—Cisplatin—esophageal cancer	0.00334	0.00339	CcSEcCtD
Cetirizine—Abdominal distension—Capecitabine—esophageal cancer	0.00334	0.00339	CcSEcCtD
Cetirizine—Diabetes mellitus—Methotrexate—esophageal cancer	0.00328	0.00333	CcSEcCtD
Cetirizine—Bronchospasm—Capecitabine—esophageal cancer	0.00326	0.00331	CcSEcCtD
Cetirizine—Polyuria—Methotrexate—esophageal cancer	0.00325	0.0033	CcSEcCtD
Cetirizine—Immune system disorder—Cisplatin—esophageal cancer	0.00325	0.0033	CcSEcCtD
Cetirizine—Sweating increased—Capecitabine—esophageal cancer	0.00323	0.00328	CcSEcCtD
Cetirizine—Arrhythmia—Cisplatin—esophageal cancer	0.00322	0.00326	CcSEcCtD
Cetirizine—Cinnarizine—CYP2A6—esophageal cancer	0.00319	0.214	CrCbGaD
Cetirizine—Bronchitis—Capecitabine—esophageal cancer	0.00319	0.00324	CcSEcCtD
Cetirizine—Alopecia—Cisplatin—esophageal cancer	0.00318	0.00323	CcSEcCtD
Cetirizine—Dysuria—Capecitabine—esophageal cancer	0.0031	0.00315	CcSEcCtD
Cetirizine—Flatulence—Cisplatin—esophageal cancer	0.00309	0.00313	CcSEcCtD
Cetirizine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00308	0.00313	CcSEcCtD
Cetirizine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00303	0.00307	CcSEcCtD
Cetirizine—Weight increased—Capecitabine—esophageal cancer	0.00302	0.00306	CcSEcCtD
Cetirizine—Visual disturbance—Methotrexate—esophageal cancer	0.00301	0.00306	CcSEcCtD
Cetirizine—Muscle spasms—Cisplatin—esophageal cancer	0.00301	0.00306	CcSEcCtD
Cetirizine—Pneumonia—Capecitabine—esophageal cancer	0.00297	0.00302	CcSEcCtD
Cetirizine—Vision blurred—Cisplatin—esophageal cancer	0.00295	0.003	CcSEcCtD
Cetirizine—Tremor—Cisplatin—esophageal cancer	0.00294	0.00298	CcSEcCtD
Cetirizine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00291	0.00295	CcSEcCtD
Cetirizine—Stomatitis—Capecitabine—esophageal cancer	0.00288	0.00292	CcSEcCtD
Cetirizine—Jaundice—Capecitabine—esophageal cancer	0.00288	0.00292	CcSEcCtD
Cetirizine—Urinary tract infection—Capecitabine—esophageal cancer	0.00287	0.00292	CcSEcCtD
Cetirizine—Conjunctivitis—Capecitabine—esophageal cancer	0.00287	0.00292	CcSEcCtD
Cetirizine—Osteoarthritis—Methotrexate—esophageal cancer	0.00285	0.0029	CcSEcCtD
Cetirizine—Malaise—Cisplatin—esophageal cancer	0.00283	0.00287	CcSEcCtD
Cetirizine—Haematuria—Capecitabine—esophageal cancer	0.00282	0.00286	CcSEcCtD
Cetirizine—Epistaxis—Capecitabine—esophageal cancer	0.00279	0.00283	CcSEcCtD
Cetirizine—Irritability—Methotrexate—esophageal cancer	0.00272	0.00277	CcSEcCtD
Cetirizine—Convulsion—Cisplatin—esophageal cancer	0.00271	0.00276	CcSEcCtD
Cetirizine—Mood swings—Methotrexate—esophageal cancer	0.0027	0.00275	CcSEcCtD
Cetirizine—Ataxia—Methotrexate—esophageal cancer	0.00268	0.00273	CcSEcCtD
Cetirizine—Myalgia—Cisplatin—esophageal cancer	0.00267	0.00271	CcSEcCtD
Cetirizine—Rhinitis—Capecitabine—esophageal cancer	0.00266	0.0027	CcSEcCtD
Cetirizine—Anxiety—Cisplatin—esophageal cancer	0.00266	0.0027	CcSEcCtD
Cetirizine—Hepatitis—Capecitabine—esophageal cancer	0.00265	0.00269	CcSEcCtD
Cetirizine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00265	0.00269	CcSEcCtD
Cetirizine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00264	0.00268	CcSEcCtD
Cetirizine—Discomfort—Cisplatin—esophageal cancer	0.00264	0.00268	CcSEcCtD
Cetirizine—Pharyngitis—Capecitabine—esophageal cancer	0.00263	0.00267	CcSEcCtD
Cetirizine—Urinary tract disorder—Capecitabine—esophageal cancer	0.00262	0.00266	CcSEcCtD
Cetirizine—Oedema peripheral—Capecitabine—esophageal cancer	0.00261	0.00265	CcSEcCtD
Cetirizine—Urethral disorder—Capecitabine—esophageal cancer	0.0026	0.00264	CcSEcCtD
Cetirizine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00256	0.0026	CcSEcCtD
Cetirizine—Oedema—Cisplatin—esophageal cancer	0.00256	0.0026	CcSEcCtD
Cetirizine—Visual impairment—Capecitabine—esophageal cancer	0.00256	0.0026	CcSEcCtD
Cetirizine—Infection—Cisplatin—esophageal cancer	0.00254	0.00258	CcSEcCtD
Cetirizine—Nervous system disorder—Cisplatin—esophageal cancer	0.00251	0.00255	CcSEcCtD
Cetirizine—Thrombocytopenia—Cisplatin—esophageal cancer	0.0025	0.00254	CcSEcCtD
Cetirizine—Tachycardia—Cisplatin—esophageal cancer	0.0025	0.00253	CcSEcCtD
Cetirizine—Skin disorder—Cisplatin—esophageal cancer	0.00248	0.00252	CcSEcCtD
Cetirizine—Eye disorder—Capecitabine—esophageal cancer	0.00248	0.00252	CcSEcCtD
Cetirizine—Tinnitus—Capecitabine—esophageal cancer	0.00247	0.00251	CcSEcCtD
Cetirizine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00247	0.00251	CcSEcCtD
Cetirizine—Flushing—Capecitabine—esophageal cancer	0.00246	0.0025	CcSEcCtD
Cetirizine—Cardiac disorder—Capecitabine—esophageal cancer	0.00246	0.0025	CcSEcCtD
Cetirizine—Anorexia—Cisplatin—esophageal cancer	0.00244	0.00247	CcSEcCtD
Cetirizine—Immune system disorder—Capecitabine—esophageal cancer	0.0024	0.00243	CcSEcCtD
Cetirizine—Hypotension—Cisplatin—esophageal cancer	0.00239	0.00243	CcSEcCtD
Cetirizine—Chills—Capecitabine—esophageal cancer	0.00238	0.00242	CcSEcCtD
Cetirizine—Arrhythmia—Capecitabine—esophageal cancer	0.00237	0.00241	CcSEcCtD
Cetirizine—Alopecia—Capecitabine—esophageal cancer	0.00234	0.00238	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00233	0.00236	CcSEcCtD
Cetirizine—Mental disorder—Capecitabine—esophageal cancer	0.00232	0.00236	CcSEcCtD
Cetirizine—Dysuria—Methotrexate—esophageal cancer	0.00231	0.00234	CcSEcCtD
Cetirizine—Paraesthesia—Cisplatin—esophageal cancer	0.0023	0.00233	CcSEcCtD
Cetirizine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00229	0.00233	CcSEcCtD
Cetirizine—Dyspnoea—Cisplatin—esophageal cancer	0.00228	0.00231	CcSEcCtD
Cetirizine—Flatulence—Capecitabine—esophageal cancer	0.00228	0.00231	CcSEcCtD
Cetirizine—Dysgeusia—Capecitabine—esophageal cancer	0.00226	0.0023	CcSEcCtD
Cetirizine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00225	0.00229	CcSEcCtD
Cetirizine—Back pain—Capecitabine—esophageal cancer	0.00223	0.00227	CcSEcCtD
Cetirizine—Decreased appetite—Cisplatin—esophageal cancer	0.00222	0.00226	CcSEcCtD
Cetirizine—Muscle spasms—Capecitabine—esophageal cancer	0.00222	0.00225	CcSEcCtD
Cetirizine—Pneumonia—Methotrexate—esophageal cancer	0.00221	0.00225	CcSEcCtD
Cetirizine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00221	0.00224	CcSEcCtD
Cetirizine—Pain—Cisplatin—esophageal cancer	0.00219	0.00222	CcSEcCtD
Cetirizine—Vision blurred—Capecitabine—esophageal cancer	0.00218	0.00221	CcSEcCtD
Cetirizine—Tremor—Capecitabine—esophageal cancer	0.00216	0.0022	CcSEcCtD
Cetirizine—Stomatitis—Methotrexate—esophageal cancer	0.00214	0.00218	CcSEcCtD
Cetirizine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00214	0.00218	CcSEcCtD
Cetirizine—Conjunctivitis—Methotrexate—esophageal cancer	0.00214	0.00217	CcSEcCtD
Cetirizine—Feeling abnormal—Cisplatin—esophageal cancer	0.00211	0.00214	CcSEcCtD
Cetirizine—Haematuria—Methotrexate—esophageal cancer	0.0021	0.00213	CcSEcCtD
Cetirizine—Malaise—Capecitabine—esophageal cancer	0.00208	0.00211	CcSEcCtD
Cetirizine—Epistaxis—Methotrexate—esophageal cancer	0.00208	0.00211	CcSEcCtD
Cetirizine—Vertigo—Capecitabine—esophageal cancer	0.00207	0.00211	CcSEcCtD
Cetirizine—Syncope—Capecitabine—esophageal cancer	0.00207	0.0021	CcSEcCtD
Cetirizine—Palpitations—Capecitabine—esophageal cancer	0.00204	0.00207	CcSEcCtD
Cetirizine—Loss of consciousness—Capecitabine—esophageal cancer	0.00203	0.00206	CcSEcCtD
Cetirizine—Body temperature increased—Cisplatin—esophageal cancer	0.00202	0.00205	CcSEcCtD
Cetirizine—Cough—Capecitabine—esophageal cancer	0.00202	0.00205	CcSEcCtD
Cetirizine—Hypertension—Capecitabine—esophageal cancer	0.00199	0.00202	CcSEcCtD
Cetirizine—Hepatitis—Methotrexate—esophageal cancer	0.00198	0.002	CcSEcCtD
Cetirizine—Myalgia—Capecitabine—esophageal cancer	0.00197	0.002	CcSEcCtD
Cetirizine—Arthralgia—Capecitabine—esophageal cancer	0.00197	0.002	CcSEcCtD
Cetirizine—Chest pain—Capecitabine—esophageal cancer	0.00197	0.002	CcSEcCtD
Cetirizine—Pharyngitis—Methotrexate—esophageal cancer	0.00196	0.00199	CcSEcCtD
Cetirizine—Anxiety—Capecitabine—esophageal cancer	0.00196	0.00199	CcSEcCtD
Cetirizine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00195	0.00198	CcSEcCtD
Cetirizine—Urinary tract disorder—Methotrexate—esophageal cancer	0.00195	0.00198	CcSEcCtD
Cetirizine—Discomfort—Capecitabine—esophageal cancer	0.00194	0.00197	CcSEcCtD
Cetirizine—Urethral disorder—Methotrexate—esophageal cancer	0.00194	0.00197	CcSEcCtD
Cetirizine—Dry mouth—Capecitabine—esophageal cancer	0.00192	0.00195	CcSEcCtD
Cetirizine—Visual impairment—Methotrexate—esophageal cancer	0.0019	0.00193	CcSEcCtD
Cetirizine—Confusional state—Capecitabine—esophageal cancer	0.0019	0.00193	CcSEcCtD
Cetirizine—Oedema—Capecitabine—esophageal cancer	0.00188	0.00191	CcSEcCtD
Cetirizine—Hypersensitivity—Cisplatin—esophageal cancer	0.00188	0.00191	CcSEcCtD
Cetirizine—Infection—Capecitabine—esophageal cancer	0.00187	0.0019	CcSEcCtD
Cetirizine—Shock—Capecitabine—esophageal cancer	0.00185	0.00188	CcSEcCtD
Cetirizine—Nervous system disorder—Capecitabine—esophageal cancer	0.00185	0.00188	CcSEcCtD
Cetirizine—Eye disorder—Methotrexate—esophageal cancer	0.00185	0.00187	CcSEcCtD
Cetirizine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00185	0.00187	CcSEcCtD
Cetirizine—Tinnitus—Methotrexate—esophageal cancer	0.00184	0.00187	CcSEcCtD
Cetirizine—Tachycardia—Capecitabine—esophageal cancer	0.00184	0.00187	CcSEcCtD
Cetirizine—Asthenia—Cisplatin—esophageal cancer	0.00183	0.00186	CcSEcCtD
Cetirizine—Cardiac disorder—Methotrexate—esophageal cancer	0.00183	0.00186	CcSEcCtD
Cetirizine—Skin disorder—Capecitabine—esophageal cancer	0.00183	0.00186	CcSEcCtD
Cetirizine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00182	0.00185	CcSEcCtD
Cetirizine—Fexofenadine—ABCB1—esophageal cancer	0.00182	0.122	CrCbGaD
Cetirizine—Anorexia—Capecitabine—esophageal cancer	0.0018	0.00182	CcSEcCtD
Cetirizine—Immune system disorder—Methotrexate—esophageal cancer	0.00178	0.00181	CcSEcCtD
Cetirizine—Chills—Methotrexate—esophageal cancer	0.00177	0.0018	CcSEcCtD
Cetirizine—Hypotension—Capecitabine—esophageal cancer	0.00176	0.00179	CcSEcCtD
Cetirizine—Diarrhoea—Cisplatin—esophageal cancer	0.00175	0.00178	CcSEcCtD
Cetirizine—Alopecia—Methotrexate—esophageal cancer	0.00175	0.00177	CcSEcCtD
Cetirizine—Mental disorder—Methotrexate—esophageal cancer	0.00173	0.00176	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00172	0.00174	CcSEcCtD
Cetirizine—Insomnia—Capecitabine—esophageal cancer	0.0017	0.00173	CcSEcCtD
Cetirizine—Paraesthesia—Capecitabine—esophageal cancer	0.00169	0.00172	CcSEcCtD
Cetirizine—Dysgeusia—Methotrexate—esophageal cancer	0.00168	0.00171	CcSEcCtD
Cetirizine—Dyspnoea—Capecitabine—esophageal cancer	0.00168	0.00171	CcSEcCtD
Cetirizine—Back pain—Methotrexate—esophageal cancer	0.00166	0.00169	CcSEcCtD
Cetirizine—Dyspepsia—Capecitabine—esophageal cancer	0.00166	0.00168	CcSEcCtD
Cetirizine—Decreased appetite—Capecitabine—esophageal cancer	0.00164	0.00166	CcSEcCtD
Cetirizine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00163	0.00165	CcSEcCtD
Cetirizine—Vomiting—Cisplatin—esophageal cancer	0.00163	0.00165	CcSEcCtD
Cetirizine—Fatigue—Capecitabine—esophageal cancer	0.00163	0.00165	CcSEcCtD
Cetirizine—Vision blurred—Methotrexate—esophageal cancer	0.00162	0.00164	CcSEcCtD
Cetirizine—Rash—Cisplatin—esophageal cancer	0.00161	0.00164	CcSEcCtD
Cetirizine—Constipation—Capecitabine—esophageal cancer	0.00161	0.00164	CcSEcCtD
Cetirizine—Pain—Capecitabine—esophageal cancer	0.00161	0.00164	CcSEcCtD
Cetirizine—Dermatitis—Cisplatin—esophageal cancer	0.00161	0.00164	CcSEcCtD
Cetirizine—Ill-defined disorder—Methotrexate—esophageal cancer	0.0016	0.00162	CcSEcCtD
Cetirizine—Feeling abnormal—Capecitabine—esophageal cancer	0.00155	0.00158	CcSEcCtD
Cetirizine—Malaise—Methotrexate—esophageal cancer	0.00155	0.00157	CcSEcCtD
Cetirizine—Vertigo—Methotrexate—esophageal cancer	0.00154	0.00157	CcSEcCtD
Cetirizine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00154	0.00156	CcSEcCtD
Cetirizine—Nausea—Cisplatin—esophageal cancer	0.00152	0.00154	CcSEcCtD
Cetirizine—Cough—Methotrexate—esophageal cancer	0.0015	0.00152	CcSEcCtD
Cetirizine—Urticaria—Capecitabine—esophageal cancer	0.0015	0.00152	CcSEcCtD
Cetirizine—Abdominal pain—Capecitabine—esophageal cancer	0.00149	0.00151	CcSEcCtD
Cetirizine—Body temperature increased—Capecitabine—esophageal cancer	0.00149	0.00151	CcSEcCtD
Cetirizine—Convulsion—Methotrexate—esophageal cancer	0.00149	0.00151	CcSEcCtD
Cetirizine—Myalgia—Methotrexate—esophageal cancer	0.00146	0.00149	CcSEcCtD
Cetirizine—Arthralgia—Methotrexate—esophageal cancer	0.00146	0.00149	CcSEcCtD
Cetirizine—Chest pain—Methotrexate—esophageal cancer	0.00146	0.00149	CcSEcCtD
Cetirizine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00145	0.00148	CcSEcCtD
Cetirizine—Discomfort—Methotrexate—esophageal cancer	0.00145	0.00147	CcSEcCtD
Cetirizine—Confusional state—Methotrexate—esophageal cancer	0.00141	0.00144	CcSEcCtD
Cetirizine—Anaphylactic shock—Methotrexate—esophageal cancer	0.0014	0.00142	CcSEcCtD
Cetirizine—Infection—Methotrexate—esophageal cancer	0.00139	0.00142	CcSEcCtD
Cetirizine—Hypersensitivity—Capecitabine—esophageal cancer	0.00139	0.00141	CcSEcCtD
Cetirizine—Nefazodone—ABCB1—esophageal cancer	0.00138	0.0923	CrCbGaD
Cetirizine—Nervous system disorder—Methotrexate—esophageal cancer	0.00138	0.0014	CcSEcCtD
Cetirizine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00137	0.00139	CcSEcCtD
Cetirizine—Skin disorder—Methotrexate—esophageal cancer	0.00136	0.00138	CcSEcCtD
Cetirizine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00136	0.00138	CcSEcCtD
Cetirizine—Asthenia—Capecitabine—esophageal cancer	0.00135	0.00137	CcSEcCtD
Cetirizine—Anorexia—Methotrexate—esophageal cancer	0.00134	0.00136	CcSEcCtD
Cetirizine—Pruritus—Capecitabine—esophageal cancer	0.00133	0.00135	CcSEcCtD
Cetirizine—Hypotension—Methotrexate—esophageal cancer	0.00131	0.00133	CcSEcCtD
Cetirizine—Diarrhoea—Capecitabine—esophageal cancer	0.00129	0.00131	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00128	0.0013	CcSEcCtD
Cetirizine—Trazodone—ABCB1—esophageal cancer	0.00128	0.0854	CrCbGaD
Cetirizine—Insomnia—Methotrexate—esophageal cancer	0.00127	0.00129	CcSEcCtD
Cetirizine—Haloperidol—ABCB1—esophageal cancer	0.00127	0.0848	CrCbGaD
Cetirizine—Paraesthesia—Methotrexate—esophageal cancer	0.00126	0.00128	CcSEcCtD
Cetirizine—Dyspnoea—Methotrexate—esophageal cancer	0.00125	0.00127	CcSEcCtD
Cetirizine—Somnolence—Methotrexate—esophageal cancer	0.00125	0.00127	CcSEcCtD
Cetirizine—Dizziness—Capecitabine—esophageal cancer	0.00125	0.00127	CcSEcCtD
Cetirizine—Dyspepsia—Methotrexate—esophageal cancer	0.00124	0.00125	CcSEcCtD
Cetirizine—Decreased appetite—Methotrexate—esophageal cancer	0.00122	0.00124	CcSEcCtD
Cetirizine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00121	0.00123	CcSEcCtD
Cetirizine—Fatigue—Methotrexate—esophageal cancer	0.00121	0.00123	CcSEcCtD
Cetirizine—Pain—Methotrexate—esophageal cancer	0.0012	0.00122	CcSEcCtD
Cetirizine—Vomiting—Capecitabine—esophageal cancer	0.0012	0.00122	CcSEcCtD
Cetirizine—Rash—Capecitabine—esophageal cancer	0.00119	0.00121	CcSEcCtD
Cetirizine—Dermatitis—Capecitabine—esophageal cancer	0.00119	0.00121	CcSEcCtD
Cetirizine—Headache—Capecitabine—esophageal cancer	0.00118	0.0012	CcSEcCtD
Cetirizine—Loperamide—ABCB1—esophageal cancer	0.00116	0.0775	CrCbGaD
Cetirizine—Feeling abnormal—Methotrexate—esophageal cancer	0.00116	0.00117	CcSEcCtD
Cetirizine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00115	0.00116	CcSEcCtD
Cetirizine—Nausea—Capecitabine—esophageal cancer	0.00112	0.00114	CcSEcCtD
Cetirizine—Urticaria—Methotrexate—esophageal cancer	0.00111	0.00113	CcSEcCtD
Cetirizine—Abdominal pain—Methotrexate—esophageal cancer	0.00111	0.00113	CcSEcCtD
Cetirizine—Body temperature increased—Methotrexate—esophageal cancer	0.00111	0.00113	CcSEcCtD
Cetirizine—Hypersensitivity—Methotrexate—esophageal cancer	0.00103	0.00105	CcSEcCtD
Cetirizine—Asthenia—Methotrexate—esophageal cancer	0.00101	0.00102	CcSEcCtD
Cetirizine—Pruritus—Methotrexate—esophageal cancer	0.000993	0.00101	CcSEcCtD
Cetirizine—Diarrhoea—Methotrexate—esophageal cancer	0.00096	0.000975	CcSEcCtD
Cetirizine—Dizziness—Methotrexate—esophageal cancer	0.000928	0.000942	CcSEcCtD
Cetirizine—Vomiting—Methotrexate—esophageal cancer	0.000892	0.000906	CcSEcCtD
Cetirizine—Rash—Methotrexate—esophageal cancer	0.000885	0.000898	CcSEcCtD
Cetirizine—Dermatitis—Methotrexate—esophageal cancer	0.000884	0.000897	CcSEcCtD
Cetirizine—Headache—Methotrexate—esophageal cancer	0.000879	0.000892	CcSEcCtD
Cetirizine—Nausea—Methotrexate—esophageal cancer	0.000833	0.000846	CcSEcCtD
Cetirizine—Quetiapine—ABCB1—esophageal cancer	0.000801	0.0537	CrCbGaD
